Faculty

Institution

Unit

Venue

Teresita Bellido

Professor and Chair of the Department of Physiology and Cell Biology

University of Arkansas for Medical Sciences

Affiliations

Center for Musculoskeletal Research

Teresita Bellido is currently serving as a Center For Musculoskeletal Research Professor and Chair of the Department of Physiology and Cell Biology at University of Arkansas For Medical Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Teresita Bellido

University of Arkansas for Medical Sciences

Professor and Chair of the Department of Physiology and Cell Biology

You can click a keyword to filter the displayed items

bone research regenerative medicine cell biology bone metabolism bone homeostasis physiology orthopaedic research pharmacology tumor biology mechanobiology bone disease vascular biology immunology endocrinology bone health osteoporosis inflammation cell signaling membrane biology cell death stem cell research bone repair mammalian biology apoptosis medicinal research bone remodeling bone density biological chemistry cartilage musculoskeletal disorders parathyroid hormone cellular physiology sclerostin cancer biology liver physiology glucocorticoids therapeutic efficacy enzyme inhibition metabolic bone disease signaling pathways bone formation osteocyte apoptosis cellular biochemistry novel therapies fracture healing in vivo systems bone cells bone mass clinical biochemistry clinical investigation therapy resistance mechanotransduction osteopathy orthopedic biomechanics multiple myeloma receptor tyrosine kinases transcription regulation redox signaling receptor (biochemistry) tumor suppressors sex steroids mechanical loading osteocyte viability clinical physiology clinical medicine musculoskeletal science osmotic stress cytokines osteoblast apoptosis bone loss osteoblastic cells estrogen receptor asbmr workshop mechanical stimulation age-associated oxidative stress skeletal involution signal transduction

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abaloparatide is More Potent Than Teriparatide in Restoring Bone Mass and Strength in Type 1 Diabetic Male Mice. Bone (2024)

Silvia MarinoSerra Ucer OzgurelKevin McAndrewsMeloney CregorAlma VillaseñorMaricuz Mamani-HuancaCoral BarbasArancha GortazarAmy Y. SatoTeresita Bellido

pharmacologybone healthdiabetic male micebone massdiabetesbone researchbone metabolism

Bisphosphonates for Osteoporosis: From Bench to Clinic. Journal of Clinical Investigation (2024)

Teresita Bellido

pharmacologyurologyosteoporosisbone repairclinical chemistrybiomarkersanesthesiologyclinical investigationorthopaedic researchmechanobiologyclinical pharmacologyclinical researchbone researchosteocalcinclinical biochemistrybone metabolismsynthetic bone substituteregenerative medicine

Generation of Bt-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss. Journal of Medicinal Chemistry (2024)

Xiuqi WangAmy Y. SatoSilvia MarinoNisreen AkelGunnar BoysenAlexei G. BasnakianTeresita M. BellidoHong-Yu Li

medicinal chemistrybone healthbiomolecular engineeringbone researchmedicinal researchtherapeutic targetsglucocorticoid-induced bone loss

Novel Ccl3-Hmgb1 Signaling Axis Regulating Osteocyte Rankl Expression in Multiple Myeloma. Haematologica (2024)

Aric AnloagueHayley M. SabolJapneet KaurSharmin KhanCody AshbyCarolina SchinkeC. Lowry BarnesFarah AlturkmaniElena AmbroginiMichael Tveden GundesenThomas LundAnne Kristine AmstrupThomas Levin AndersenMarta Diaz-delCastilloG. David RoodmanTeresita BellidoJesus Delgado-Calle

osteocyte rankl expressionmultiple myelomacell biologybone homeostasishematology

Pharmacological Inhibition of Hif2 Protects Against Bone Loss in an Experimental Model of Estrogen Deficiency. Proceedings of the National Academy of Sciences (2024)

Giulia LanzollaElena SabiniKatherine BeigelMohd Parvez KhanXiaowei Sherry LiuDian WangBrittany LaslowDeanne TaylorTeresita BellidoAmato GiacciaErnestina Schipani

pharmacologyendocrinologypharmacological inhibitionbone lossestrogen deficiencyexperimental model

Pharmacologic or Genetic Interference With Atrogene Signaling Protects From Glucocorticoid-Induced Musculoskeletal and Cardiac Disease. JCI Insight (2024)

Amy Y SatoMeloney CregorKevin McAndrewsCharles A SchurmanEric SchaibleJennifer ShutterPunit VyasBhawana AdhikariMonte S WillisMarjan BoermaTamara AllistonTeresita Bellido

geneticsmusculoskeletal tissuesgene expressiongenetic interferencecardiac diseasemusculoskeletal functionglucocorticoidsglucocorticoid-induced musculoskeletalmusculoskeletal disorders

Pth Receptor Signalling, Osteocytes and Bone Disease Induced by Diabetes Mellitus. Nature Reviews Endocrinology (2024)

Silvia MarinoTeresita Bellido

hypertensionreceptor tyrosine kinasescartilagegeneticspth receptor signallingmechanobiologyheme signalingtumor biologyvascular biologycardiovascular diseasepharmacologycardiovascular researchredox signalingimmunologystem cell researchsignaling pathwaysobesity medicinereceptor (biochemistry)obesity

Sclerostin Antibody Corrects Periodontal Disease in Type 2 Diabetic Mice. JCI Insight (2024)

Hakan TurkkahramanShannan FlanaganTianli ZhuNisreen AkelSilvia MarinoDayane Ortega-GonzalezXue YuanTeresita M. Bellido

periodontal diseaseperiodontologyoral medicineophthalmologyoral diseasesoral biologysclerostin antibodydiabetesimmunologydermatology

Author Correction: Reversal of the Diabetic Bone Signature With Anabolic Therapies in Mice. Bone Research (2023)

Silvia MarinoNisreen AkelShenyang LiMeloney CregorMeghan JonesBetiana PerezGaston TroncosoJomeeka MeeksScott StewartAmy Y. SatoIntawat NookaewTeresita Bellido

health sciencesmetabolic bone diseasediabetes therapiesanabolic therapiesdiabetes researchtherapeutic efficacydiabetic bone signaturediabetesbone researchnovel therapiesbone metabolismbone disease

Data From Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction Without Gut Toxicity. (2023)

Hayley M. SabolAdam J. FerrariManish AdhikariTânia AmorimKevin McAndrewsJudith AndersonMichele VigoloRajwinder LehalMeloney CregorSharmin KhanPedro L. CuevasJill A. HelmsNoriyoshi KuriharaVenkat SrinivasanFrank H. EbetinoRobert K. BoeckmanG. David RoodmanTeresita BellidoJesus Delgado-Calle

tumor targetinggut toxicitycell biologyhematologycancer biologytumor growthcancer researchdermatologypharmacologymedical mycologyoncologybone destructioncellular therapynotch inhibitorshematological malignanciescancer immunotherapyenzyme inhibitiontherapeutic efficacybone researchmedicinal researchtherapeutic targetscancer growth

1
2
3
4
5
15
10 / page

Teresita Bellido

Professor and Chair of the Department of Physiology and Cell Biology

University of Arkansas for Medical Sciences

Affiliations

Center for Musculoskeletal Research

Teresita Bellido is currently serving as a Center For Musculoskeletal Research Professor and Chair of the Department of Physiology and Cell Biology at University of Arkansas For Medical Sciences.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Teresita Bellido

University of Arkansas for Medical Sciences

Professor and Chair of the Department of Physiology and Cell Biology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abaloparatide is More Potent Than Teriparatide in Restoring Bone Mass and Strength in Type 1 Diabetic Male Mice. Bone (2024)

Silvia MarinoSerra Ucer OzgurelKevin McAndrewsMeloney CregorAlma VillaseñorMaricuz Mamani-HuancaCoral BarbasArancha GortazarAmy Y. SatoTeresita Bellido

pharmacologybone healthdiabetic male micebone massdiabetesbone researchbone metabolism

Bisphosphonates for Osteoporosis: From Bench to Clinic. Journal of Clinical Investigation (2024)

Teresita Bellido

Generation of Bt-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss. Journal of Medicinal Chemistry (2024)

Xiuqi WangAmy Y. SatoSilvia MarinoNisreen AkelGunnar BoysenAlexei G. BasnakianTeresita M. BellidoHong-Yu Li

medicinal chemistrybone healthbiomolecular engineeringbone researchmedicinal researchtherapeutic targetsglucocorticoid-induced bone loss

Novel Ccl3-Hmgb1 Signaling Axis Regulating Osteocyte Rankl Expression in Multiple Myeloma. Haematologica (2024)

osteocyte rankl expressionmultiple myelomacell biologybone homeostasishematology

Pharmacological Inhibition of Hif2 Protects Against Bone Loss in an Experimental Model of Estrogen Deficiency. Proceedings of the National Academy of Sciences (2024)

Giulia LanzollaElena SabiniKatherine BeigelMohd Parvez KhanXiaowei Sherry LiuDian WangBrittany LaslowDeanne TaylorTeresita BellidoAmato GiacciaErnestina Schipani

pharmacologyendocrinologypharmacological inhibitionbone lossestrogen deficiencyexperimental model

Pharmacologic or Genetic Interference With Atrogene Signaling Protects From Glucocorticoid-Induced Musculoskeletal and Cardiac Disease. JCI Insight (2024)

Amy Y SatoMeloney CregorKevin McAndrewsCharles A SchurmanEric SchaibleJennifer ShutterPunit VyasBhawana AdhikariMonte S WillisMarjan BoermaTamara AllistonTeresita Bellido

geneticsmusculoskeletal tissuesgene expressiongenetic interferencecardiac diseasemusculoskeletal functionglucocorticoidsglucocorticoid-induced musculoskeletalmusculoskeletal disorders

Pth Receptor Signalling, Osteocytes and Bone Disease Induced by Diabetes Mellitus. Nature Reviews Endocrinology (2024)

Silvia MarinoTeresita Bellido

Sclerostin Antibody Corrects Periodontal Disease in Type 2 Diabetic Mice. JCI Insight (2024)

Hakan TurkkahramanShannan FlanaganTianli ZhuNisreen AkelSilvia MarinoDayane Ortega-GonzalezXue YuanTeresita M. Bellido

periodontal diseaseperiodontologyoral medicineophthalmologyoral diseasesoral biologysclerostin antibodydiabetesimmunologydermatology

Author Correction: Reversal of the Diabetic Bone Signature With Anabolic Therapies in Mice. Bone Research (2023)

Silvia MarinoNisreen AkelShenyang LiMeloney CregorMeghan JonesBetiana PerezGaston TroncosoJomeeka MeeksScott StewartAmy Y. SatoIntawat NookaewTeresita Bellido

health sciencesmetabolic bone diseasediabetes therapiesanabolic therapiesdiabetes researchtherapeutic efficacydiabetic bone signaturediabetesbone researchnovel therapiesbone metabolismbone disease

Data From Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction Without Gut Toxicity. (2023)

1
2
3
4
5
15
10 / page

Similar Faculty Members

Alexander G. Robling

Institution

Indiana University – Purdue University Indianapolis

orthopaedic surgery

bone research

Larry Suva

Institution

Texas A&M University

orthopaedic surgery

health science

Lilian I. Plotkin

Institution

Indiana University – Purdue University Indianapolis

bone homeostasis

bone research

Laurie Mccauley

Institution

University of Michigan

bone research

cell biology

Evan Keller

Institution

University of Michigan

prostate cancer

urology

Thomas J. Rosol

Institution

Ohio University

cancer risk

bone pathology

Ernestina Schipani

Institution

University of Pennsylvania

regenerative medicine

bone research

Carlos M. Isales

Institution

Augusta University

endocrinology

metabolic health

David W. Rowe

Institution

University of Connecticut

cellular differentiation

orthopaedic surgery

Meghan McGee-Lawrence

Institution

Augusta University

osteoporosis

skeletal homeostasis

Similar Faculty Members

Alexander G. Robling

Institution

Indiana University – Purdue University Indianapolis

orthopaedic surgery

bone research

Larry Suva

Institution

Texas A&M University

orthopaedic surgery

health science

Lilian I. Plotkin

Institution

Indiana University – Purdue University Indianapolis

bone homeostasis

bone research

Laurie Mccauley

Institution

University of Michigan

bone research

cell biology

Evan Keller

Institution

University of Michigan

prostate cancer

urology

Thomas J. Rosol

Institution

Ohio University

cancer risk

bone pathology

Ernestina Schipani

Institution

University of Pennsylvania

regenerative medicine

bone research

Carlos M. Isales

Institution

Augusta University

endocrinology

metabolic health

David W. Rowe

Institution

University of Connecticut

cellular differentiation

orthopaedic surgery

Meghan McGee-Lawrence

Institution

Augusta University

osteoporosis

skeletal homeostasis